![](/img/cover-not-exists.png)
Potential Utility of Telmisartan, an Angiotensin II Type 1 Receptor Blocker with Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ)-Modulating Activity for the Treatment of Cardiometabolic Disorders
Sho-ichi Yamagishi, Bentham Science Publisher, Kazuo Nakamura, Bentham Science Publisher, Takanori Matsui, Bentham Science PublisherVolume:
7
Language:
english
Journal:
Current Molecular Medicine
DOI:
10.2174/156652407781387073
Date:
August, 2007
File:
PDF, 76 KB
english, 2007